Maynard Um
-
-
-
-
-
-
-
KeyBanc on Life Sciences Tools & Services: 'We Highlight Our Favored 2026 "Tools" Stocks'
-
-
-
-
-
-
-
Evercore ISI Upgrades Repligen (NASDAQ: RGEN) to Outperform (correction)
-
-
-
-
-
-
-
Barclays Starts Repligen (RGEN) at Overweight
-
-
-
-
-
-
-
Repligen (RGEN) Tops Q1 EPS by 4c, provides guidance
-
-
-
-
-
-
-
Repligen (RGEN) PT Raised to $170 at Canaccord Genuity
-
-
-
-
-
-
-
Repligen (RGEN) Launches Novel AVIPure dsRNA Resin in OPUSĀ® Pre-packed Columns
-
-
-
-
-
-
-
Stifel on Repligen (RGEN) M&A Speculation with Maravai (MRVI)
-
341,965 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

